These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 26838245

  • 21. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Cesana C, Klersy C, Barbarano L, Nosari AM, Crugnola M, Pungolino E, Gargantini L, Granata S, Valentini M, Morra E.
    J Clin Oncol; 2002 Mar 15; 20(6):1625-34. PubMed ID: 11896113
    [Abstract] [Full Text] [Related]

  • 22. Increased sialylation of oligosaccharides on IgG paraproteins--a potential new tumour marker in multiple myeloma.
    Fleming SC, Smith S, Knowles D, Skillen A, Self CH.
    J Clin Pathol; 1998 Nov 15; 51(11):825-30. PubMed ID: 10193323
    [Abstract] [Full Text] [Related]

  • 23. Monoclonal gammopathy of undetermined significance (MGUS) in patients with solid tumors: effects of chemotherapy on the monoclonal protein.
    Anagnostopoulos A, Galani E, Gika D, Sotou D, Evangelopoulou A, Dimopoulos MA.
    Ann Hematol; 2004 Oct 15; 83(10):658-60. PubMed ID: 15278296
    [Abstract] [Full Text] [Related]

  • 24. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
    Anagnostopoulos A, Evangelopoulou A, Sotou D, Gika D, Mitsibounas D, Dimopoulos MA.
    Ann Hematol; 2002 Jul 15; 81(7):357-61. PubMed ID: 12185503
    [Abstract] [Full Text] [Related]

  • 25. Multiparameter immunophenotyping by flow cytometry as a diagnostic tool in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Carulli G, Ottaviano V, Cannizzo E, Giuntini S, Manetti C, Ciancia EM, Azzarà A.
    Clin Ter; 2012 Jul 15; 163(5):387-92. PubMed ID: 23099966
    [Abstract] [Full Text] [Related]

  • 26. Distortions but not Definitive Peaks by Capillary Serum Protein Electrophoresis Indicate Monoclonal Gammopathy of Undetermined Significance rather than Multiple Myeloma.
    Liang CA, Zhang L, Segal G, Dasgupta A, Nguyen AND, Wahed A.
    Ann Clin Lab Sci; 2020 Jan 15; 50(1):151-152. PubMed ID: 32161026
    [Abstract] [Full Text] [Related]

  • 27. Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma.
    Allegra A, Innao V, Allegra AG, Pugliese M, Di Salvo E, Ventura-Spagnolo E, Musolino C, Gangemi S.
    Int J Mol Sci; 2019 Jun 10; 20(11):. PubMed ID: 31185596
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor Disease.
    Hofmann JN, Mailankody S, Korde N, Wang Y, Tageja N, Costello R, Zingone A, Hultcrantz M, Pollak MN, Purdue MP, Landgren O.
    Obesity (Silver Spring); 2017 Aug 10; 25(8):1317-1320. PubMed ID: 28602036
    [Abstract] [Full Text] [Related]

  • 30. Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myeloma.
    Grass S, Iida S, Wikowicz A, Preuss KD, Inagaki A, Shimizu K, Ziepert M, Ueda R, Pfreundschuh M.
    Cancer Sci; 2011 Mar 10; 102(3):565-8. PubMed ID: 21205072
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Active multiple myeloma suppresses and typically eliminates coexisting MGUS.
    Campbell JP, Heaney JLJ, Pandya S, Afzal Z, Kaiser M, Owen R, Child JA, Gregory W, Morgan GJ, Jackson GH, Bunce CM, Drayson MT.
    Br J Cancer; 2017 Sep 05; 117(6):835-839. PubMed ID: 28728165
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia): A Preliminary Clinical Study.
    Golombick T, Diamond TH, Manoharan A, Ramakrishna R.
    Integr Cancer Ther; 2016 Jun 05; 15(2):183-9. PubMed ID: 27154182
    [Abstract] [Full Text] [Related]

  • 38. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
    Eisele L, Dürig J, Hüttmann A, Dührsen U, Assert R, Bokhof B, Erbel R, Mann K, Jöckel KH, Moebus S, Heinz Nixdorf Recall Study Investigative Group.
    Ann Hematol; 2012 Feb 05; 91(2):243-8. PubMed ID: 21789623
    [Abstract] [Full Text] [Related]

  • 39. [Isotypic characterization of IgA paraproteins: association with other clinical and analytic data].
    González González JB, García Delgado R, Cámara Sáez E, Ortiz Maslloréns F.
    Rev Clin Esp; 1996 Aug 05; 196(8):529-35. PubMed ID: 8984539
    [Abstract] [Full Text] [Related]

  • 40. Discrepant serum creatinine concentrations caused by paraprotein interference preceding diagnosis of monoclonal gammopathy of undetermined significance.
    Kobara M, Inaba T, Matoba S, Nakata T.
    BMJ Case Rep; 2024 Apr 25; 17(4):. PubMed ID: 38670567
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.